Heidi Jacobe, MD
Dermatology · Dallas, TXNPI 1225097538
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,885 of the $14,914 with a category attached, or 86.4%. Merck accounts for 78.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $11,735 and has fallen 99.7% since, to $33 in 2024.
Across 18 payments — averaging $828.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$12K
- Boehringer Ingelheim$3K
- AbbVie$33
- Misonix Inc$21
Across 5 payments — averaging $28,357 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$81K
- E.r. Squibb & Sons, L.L.C.$61K
What the payments were for
- Consulting fees$12,88586%
- Travel & lodging$1,3459%
- Food & beverage$6855%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 15 | $11,735 |
| Boehringer Ingelheim | 1 | $3,125 |
| AbbVie | 1 | $33 |
| Misonix Inc | 1 | $21 |
How this compares
$14,914 in reported general payments places this provider in the 80th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 12 | $99,175 |
| Gabapentin | 62 | $1,194 |
| Mycophenolate Mofetil | 19 | $1,188 |
| Triamcinolone Acetonide | 49 | $1,039 |
| Fluocinonide | 17 | $1,008 |
| Clobetasol Propionate | 28 | $898 |
| MethotrexateMethotrexate Sodium | 39 | $565 |
| Prednisone | 16 | $150 |
| Ketoconazole | 12 | $143 |
| Amlodipine Besylate | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Dallas
- Jennifer CatherDallas$1.3M
- Ross RaduskyDallas$1.2M
- Joseph MerolaDallas$1.2M
- So Yeon PaekDallas$812K
- Martin MenterDallas$512K
- Mary HornerDallas$448K
- Donald GlassDallas$347K
- William AbramovitsDallas$325K
- Mary FleischliDallas$153K
- Adean KingstonDallas$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.